The 7 analysts offering 12-month price forecasts for Kura Oncology Inc have a median target of 42.00, with a high estimate of 53.00 and a low estimate of 38.00. The median estimate represents a +123.05% increase from the last price of 18.83.
The current consensus among 8 polled investment analysts is to Buy stock in Kura Oncology Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.49
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.